Market Size of Surgical Tourniquets Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 0.55 Billion |
| Market Size (2029) | USD 0.81 Billion |
| CAGR (2024 - 2029) | 8.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Surgical Tourniquets Market Analysis
The Surgical Tourniquets Market size is estimated at USD 0.55 billion in 2024, and is expected to reach USD 0.81 billion by 2029, growing at a CAGR of 8% during the forecast period (2024-2029).
The COVID-19 pandemic significantly impacted the number of orthopedic surgeries during the initial phase. For instance, according to an article published by PubMed in August 2021, a study was conducted in Chile, showing a 22.8% decline in orthopedic surgeries during the pandemic. Furthermore, according to an article published by PubMed Central in January 2022, the COVID-19 pandemic significantly reduced the number of orthopedic trauma services during the lockdown phase. Thus, owing to the pandemic, the overall orthopedic care market was significantly impacted during the initial pandemic phase, reducing surgical tourniquets' usage. However, as the pandemic has subsided, orthopedic care has returned to normal, so the studied market is expected to have stable growth during the forecast period of the study.
Factors driving the growth of the studied market include the rise in trauma cases, the increased number of hospitals and the adoption of advanced healthcare infrastructure, and the rise in the geriatric population.
The increasing geriatric population worldwide and the rise of orthopedic diseases such as arthritis and osteoporosis are the mainstays of the surgical tourniquets market. For instance, according to an article published by Frontiers in Rehabilitation Sciences in April 2023, it is estimated that osteoarthritis affects about 3.3 to 3.6% of the population globally, and it causes moderate to severe disability in 43 million people, making it the 11th most debilitating disease worldwide. The article also stated that in the United States, it is estimated that 80% of the population over 65 years old has radiographic evidence of osteoarthritis. However, only 60% of this subset has symptoms. The growing prevalence of arthritis and the increasing burden of arthritis conditions among the elderly are expected to boost the market growth, as surgical tourniquets are expected to be increasingly used during the surgical treatment procedures of arthritis.
Furthermore, according to the World Population Prospects: 2022, published by the UN in 2022, it was estimated that the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. As a person ages, his bones become weaker, making him more prone to surgical treatments. Thus, with the aging population, the usage of surgical tourniquets is expected to increase during orthopedic surgeries, which is expected to enhance future market growth.
Hence, due to the factors above, such as the rising prevalence of orthopedic diseases such as arthritis and the rising geriatric population, the studied market is expected to experience growth during the forecast period of the study. However, factors such as the lack of skilled professionals and the risk of infectious disease transmission are expected to impede the market's growth.
